Immunogenicity of induced pluripotent stem cell-derived smooth muscle cells results from a reduction in the expression of indoleamine 2,3 dioxygenase (IDO-1).

Saved in:
Bibliographic Details
Title: Immunogenicity of induced pluripotent stem cell-derived smooth muscle cells results from a reduction in the expression of indoleamine 2,3 dioxygenase (IDO-1).
Authors: Partridge K; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK., Mehler VJ; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK.; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Burns CJ; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK., Pober JS; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA., Moore ML; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK.
Source: Regenerative medicine [Regen Med] 2026 Jan; Vol. 21 (1), pp. 9-20. Date of Electronic Publication: 2026 Feb 25.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278116 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1746-076X (Electronic) Linking ISSN: 17460751 NLM ISO Abbreviation: Regen Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41738185
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity of induced pluripotent stem cell-derived smooth muscle cells results from a reduction in the expression of indoleamine 2,3 dioxygenase (IDO-1).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Partridge+K%22">Partridge K</searchLink>; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK.<br /><searchLink fieldCode="AU" term="%22Mehler+VJ%22">Mehler VJ</searchLink>; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK.; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Burns+CJ%22">Burns CJ</searchLink>; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK.<br /><searchLink fieldCode="AU" term="%22Pober+JS%22">Pober JS</searchLink>; Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Moore+ML%22">Moore ML</searchLink>; Science and Research, Medicines and Healthcare Products Regulatory Agency (MHRA), South Mimms, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101278116%22">Regenerative medicine</searchLink> [Regen Med] 2026 Jan; Vol. 21 (1), pp. 9-20. <i>Date of Electronic Publication: </i>2026 Feb 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101278116 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1746-076X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217460751%22">17460751 </searchLink><i>NLM ISO Abbreviation: </i>Regen Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41738185
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/17460751.2026.2631599
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 9
    Titles:
      – TitleFull: Immunogenicity of induced pluripotent stem cell-derived smooth muscle cells results from a reduction in the expression of indoleamine 2,3 dioxygenase (IDO-1).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Partridge K
      – PersonEntity:
          Name:
            NameFull: Mehler VJ
      – PersonEntity:
          Name:
            NameFull: Burns CJ
      – PersonEntity:
          Name:
            NameFull: Pober JS
      – PersonEntity:
          Name:
            NameFull: Moore ML
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1746-076X
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Regenerative medicine
              Type: main
ResultId 1